Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination

QR Code

Comparative characteristics of the cellular immune response to SARS-CoV-2 during infection and post-vaccination

An important area of research concerns monitoring of immune response features in patients with SARS-CoV-2 infection as well as their analysis, as compared with characteristics of vaccine-mediated protection, in order to specify the determinants of cellular immune response. The aim of our work was to...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. N. Klyueva, S. A. Bugorkova, A. L. Kravtsov, T. N. Kashtanova, V. A. Kozhevnikov
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-01-01
Series:	Медицинская иммунология
Subjects:	covid-19 sars-cov-2 s protein peptide vaccine memory t cells cytokines
Online Access:	https://www.mimmun.ru/mimmun/article/view/2690
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of the functioning of B-2 lymphocytes in patients with common variable immune deficiency in post-vaccination immunity to SARS-CoV-2
by: L. P. Sizyakina, et al.
Published: (2023-07-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach
by: Yasamin Pahlavan, et al.
Published: (2024-12-01)

Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
by: A. V. Ivanov, et al.
Published: (2024-11-01)

Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer
by: Luminita Mărutescu, et al.
Published: (2025-06-01)

SARS-CoV-2 spike protein mutation variants: Recent advances in theragnostic and vaccines development
by: Jutishna Bora, et al.
Published: (2025-08-01)

Role of the cellular immunity in the formation of the immune response in coronavirus infections
by: I. A. Ivanova, et al.
Published: (2021-12-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Reinfection with SARS-CoV-2 variants: The issues of hybrid immunity efficiency
by: I. A. Pobozhaya, et al.
Published: (2025-06-01)

The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
by: Adi Anis Heusler, et al.
Published: (2025-12-01)

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines
by: Chengyu Hu, et al.
Published: (2025-06-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

Morphofunctional characteristics of blood cells in reconvalescents after suffering COVID-19
by: S. N. Klyueva, et al.
Published: (2022-07-01)

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest<sup>®</sup> SARS-CoV-2 ELISPOT kit
by: D. A. Poteryaev, et al.
Published: (2021-10-01)

Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff
by: M. P. Kostinov, et al.
Published: (2025-01-01)

SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
by: Marlon Yuri Garcia-Paitan, et al.
Published: (2025-07-01)

Vaccination, infection, and hybrid immunity: determinants of SARS-CoV-2 IgG antibody levels and protection in Quzhou, China
by: Zhiying Yin, et al.
Published: (2025-07-01)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)

«DELTA-VAC» SUBUNIT VACCINE INDUCES STRONG HUMORAL IMMUNE RESPONSE AGAINST SARS-COV-2
by: Valentina Sergeevna Nesmeyanova, et al.
Published: (2019-08-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
by: Rahul K. Suryawanshi, et al.
Published: (2023-12-01)

Adenovirus-Based Single-Dose Vaccines for SARS-CoV-2: A Review
by: Vivek P Chavda, et al.
Published: (2025-07-01)

Frequency of SARS-CoV-2 RNA Detection in Foreign Medical Students Vaccined against New Coronavirus Infection
by: O. A. Ryabtseva, et al.
Published: (2023-03-01)

Rabies virus-based oral and inactivated vaccines protect minks against SARS-CoV-2 infection and transmission
by: Hong Huo, et al.
Published: (2025-03-01)

Postinfectious and Postvaccinal Humoral Immune Response to SARS-CoV-2 in Adults: Qualitative and Quantitative Assessment
by: M. A. Yermalovich, et al.
Published: (2023-07-01)

SARS-CoV-2 IgG antibody response to a viral vector vaccine among health care workers in a tertiary care hospital
by: Kavitha Paul Konikkara, et al.
Published: (2025-03-01)

Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers—The ORCHESTRA Project
by: Seyedalireza Seyedi, et al.
Published: (2025-06-01)

Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
by: F. D. Partey, et al.
Published: (2025-07-01)

ELISPOT assay of the SARS-CoV-2 specific T cells immune response
by: V. V. Gerasimova, et al.
Published: (2022-12-01)

Features of post-vaccination humoral immune response in the persons who underwent COVID-19 of various severity
by: I. A. Ivanova, et al.
Published: (2023-02-01)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
by: Doris Urlaub, et al.
Published: (2021-12-01)

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine
by: João Pedro da Silva Nunes, et al.
Published: (2025-07-01)

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2024-12-01)

Immunological Approaches and Different Strategies for Vaccine Development Against SARS-COV-2
by: Muhammed Babakir-Mina
Published: (2020-12-01)

Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
by: I. O. Stoma, et al.
Published: (2024-07-01)

The bridge between anxiety and insomnia symptoms among Chinese adults before and after SARS-CoV-2 vaccination: a network analysis
by: Yan Liu, et al.
Published: (2025-07-01)

Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea
by: Sangyi Lee, et al.
Published: (2023-12-01)

Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease
by: Sally J. Lawrence, et al.
Published: (2025-05-01)